These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7908921)
1. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes. Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921 [TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor. Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391 [TBL] [Abstract][Full Text] [Related]
3. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules. Yuen MH; Macklin KD; Conti-Fine BM J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056 [TBL] [Abstract][Full Text] [Related]
4. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671 [TBL] [Abstract][Full Text] [Related]
5. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis. Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882 [TBL] [Abstract][Full Text] [Related]
6. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor. Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099 [TBL] [Abstract][Full Text] [Related]
7. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ; Oshima M; Deitiker P Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597 [TBL] [Abstract][Full Text] [Related]
8. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells. Bellone M; Ostlie N; Karachunski P; Manfredi AA; Conti-Tronconi BM J Immunol; 1993 Jul; 151(2):1025-38. PubMed ID: 7687612 [TBL] [Abstract][Full Text] [Related]
9. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656 [TBL] [Abstract][Full Text] [Related]
10. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit. Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027 [TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor. Protti MP; Manfredi AA; Wu XD; Moiola L; Dalton MW; Howard JF; Conti-Tronconi BM J Clin Invest; 1992 Oct; 90(4):1558-67. PubMed ID: 1383275 [TBL] [Abstract][Full Text] [Related]
12. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069 [TBL] [Abstract][Full Text] [Related]
13. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor. Nagvekar N; Corlett L; Jacobson LW; Matsuo H; Chalkley R; Driscoll PC; Deshpande S; Spack EG; Willcox N J Immunol; 1999 Apr; 162(7):4079-87. PubMed ID: 10201931 [TBL] [Abstract][Full Text] [Related]
14. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Atassi MZ; Oshima M Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435 [TBL] [Abstract][Full Text] [Related]
16. Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects. Moiola L; Karachunski P; Protti MP; Howard JF; Conti-Tronconi BM J Clin Invest; 1994 Mar; 93(3):1020-8. PubMed ID: 7510715 [TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor. Ragheb S; Mohamed M; Lisak RP J Neuroimmunol; 2005 Feb; 159(1-2):137-45. PubMed ID: 15652413 [TBL] [Abstract][Full Text] [Related]
18. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences. Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057 [TBL] [Abstract][Full Text] [Related]
19. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor. Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360 [TBL] [Abstract][Full Text] [Related]
20. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. Fujii Y; Lindstrom J J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]